 |
|
|
| |
Moderate Hepatic Impairment Does not Affect Doravirine Pharmacokinetics
|
| |
| |
Reported by Jules Levin
16th International Workshop on Clinical Pharmacology of HIV
& Hepatitis Therapy (IWCPHIVHT) - May 26-28, 2015 Washington, DC, USA
Sauzanne Khalilieh,1 Ka Lai Yee,1 Rachel Liu,1 Li Fan,1 Patrice Auger,2 Ilias Triantafyllou,1 Daria Stypinski,2 Kenneth C Lasseter,3 Thomas Marbury,4 Marian Iwamoto1
1Merck & Co., Inc., Kenilworth, NJ, USA; 2Celerion, Lincoln, NE, USA; 3Clinical Pharmacology of Miami, Inc., Miami, FL, USA; 4Orlando Clinical Research Center, Orlando, FL, USA
|
| |
|
|
|
|
|
